About the event
LYNPARZA launch meeting on 20th March 2024 in London and various locations across the UK. The meeting aims to support healthcare professionals involved in the care of mCRPC patients to better understand the potential clinical impact of pivotal clinical trial data; whilst providing practical considerations for applying any learnings to a clinical setting. The meeting is to also help educate HCPs on the updated NICE guidelines and the practicalities of identifying patients with mCRPC who might benefit from treatment with LYNPARZA (Olaparib).
Send an enquiry
AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines. Our Purpose is to push the boundaries of science to deliver life-changing medicines. We believe the best way we can achieve our Purpose is to put science at the centre of everything we do. Science defines who we are. It is why we come to work every day and is part of our DNA. But this is only half of the story. We know that we do not have all the answers. We want to share ideas because we believe it results in better medicines. We want the way we work to be inclusive, open and collaborative. This approach runs through all that we do.
Want to learn more?
Similar CPD Events
Healthcare & Medical
Respiratory Study Day
AstraZeneca
Upskilling clinicians on the new and updated COPD and Asthma guidelines. Understanding the cardiopul...
03 Dec 2024